Kevin Kuntz

USPTO Granted Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 10.1

ph-index = 2

Forward Citations = 26(Granted Patents)

Company Filing History:

Smithkline Beecham Corporation

patents

Years Active: 2008-2013

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8415345 - Benzene sulfonamide thiazole and oxazole compounds (2013-04-09),

2. 8093239 - Imidazopyridine kinase inhibitors (2012-01-10),

3. 7981903 - 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer (2011-07-19),

4. 7615643 - Benzimidazole thiophene compounds (2009-11-10),

5. 7462614 - Imidazotriazine compounds (2008-12-09),

Title: Inventor Kevin Kuntz: Pioneering Innovations in Durham

Introduction: Kevin Kuntz is a renowned inventor based in Durham, NC, known for his groundbreaking contributions to various fields.

Latest Patents: Kevin Kuntz holds several patents in the areas of technology and healthcare, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Kevin Kuntz has consistently pushed the boundaries of innovation, leading to significant advancements in his respective industries.

Collaborations: Throughout his career, Kevin Kuntz has collaborated with leading researchers, engineers, and professionals, fostering a culture of innovation and excellence.

Conclusion: Kevin Kuntz's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and creators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

1 patent pending (CIPO):

Please report any incorrect information to support@idiyas.com